Treatment of granuloma annulare with tofacitinib
Abstract
REFERENCES 1. Wagner G, Sachse MM. Acquired reactive perforating dermatosis. J Dtsch Dermatol Ges J Ger Soc Dermatol JDDG. 2013;11(723– 9):723– 30. https://doi.org/10.1111/ddg.12131 2. Kawakami T, Akiyama M, IshidaYamamoto A, Nakano H, Mitoma C, Yoneda K, et al. Clinical practice guide for the treatment of perforating dermatosis. J Dermatol. 2020;47:1374– 82. https://doi.org/10.1111/13468138.15647 3. HuseinElAhmed H, Steinhoff M. Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response. J Dermatol Treat. 2020;1– 7. [Online ahead of print]. https://doi.org/10.1080/09546 634.2020.1853024 4. Holm JG, Agner T, Sand C, Thomsen SF. Dupilumab for prurigo nodularis: case series and review of the literature. Dermatol Ther. 2020;33:e13222. https://doi.org/10.1111/dth.13222 5. Ying Y, Shuang C, ZhenYing Z. Dupilumab may be an alternative option in the treatment of acquired reactive perforating collagenosis combined with AD. Immun Inflamm Dis. 2021;10:e574. https://doi.org/10.1002/iid3.574
Read the paper
Related studies
- In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets
- Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery
- Anti-phytopathogenic and plant growth promoting potential of endophytic fungi isolated from Dysoxylum gotadhora
- Mercury toxicity causes iron and sulfur deficiencies along with oxidative injuries in alfalfa (Medicago sativa)
- Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo
- Assessing the Protective Effect of Moringa oleifera Extract against Bone Metastasis: An In Vitro Simulated Digestion Approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.